Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 30+ AI models, with 0% extra fees
CITIC Securities: The medical aesthetics industry is currently in a stage of rapid growth in upstream registration certificates
CITIC Securities pointed out that, based on industry data and published annual performance, although the beauty industry faces challenges such as weak demand and a phased rebound in international brand market share, its operational quality has shown positive changes by 2025: clearer positioning, further solidification of key products and series’ mind share and scale, and general breakthroughs in category expansion. Technological upgrades, scene extension, and shifting trends are driving 2026 to become a major year for new product launches across brands, with clear growth drivers on the product side. The medical aesthetics industry is currently in a stage of rapid increase in upstream registration certificates, with fierce competition, but structural opportunities continue to exist: the dividend from new products still remains, and upstream brands with strong comprehensive capabilities in marketing, customer acquisition, medical promotion, product mix, and channel operation are expected to succeed in the competition. (Jiemian News)